[EN] PYRROLIDINE-2-CARBONITRILE DERIVATIVES AND THEIR USE AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV)<br/>[FR] DERIVES DE PYRROLIDINE-2-CARBONITRILE ET LEUR UTILISATION COMME INHIBITEURS DE LA DIPEPTIDYLE PEPTIDASE-IV (DPP-IV)
申请人:ABBOTT LAB
公开号:WO2005023762A1
公开(公告)日:2005-03-17
The present invention relates to compounds of formula (I), (I), which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, syndrome X, hyperinsulinemia, b-cell failure, obesity, satiety disorders, atherosclerosis, and various immunomodulatory diseases.
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
申请人:Pei Zhonghua
公开号:US20050131019A1
公开(公告)日:2005-06-16
The present invention relates to compounds of formula (I),
which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, syndrome X, hyperinsulinemia, β-cell failure, obesity, satiety disorders, atherosclerosis, and various immunomodulatory diseases.
Modulators of methyl modifying enzymes, compositions and uses thereof
申请人:Constellation Pharmaceuticals, Inc.
公开号:US09051269B2
公开(公告)日:2015-06-09
Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
本文提供了用于调节甲基修饰酶的代理,其组成和用途。
[EN] MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF<br/>[FR] MODULATEURS D'ENZYMES DE MODIFICATION PAR MÉTHYLATION, COMPOSITIONS ET UTILISATIONS ASSOCIÉES
申请人:CONSTELLATION PHARMACEUTICALS INC
公开号:WO2013075084A8
公开(公告)日:2014-05-01
VIRAL POLYMERASE INHIBITORS
申请人:Beaulieu Pierre
公开号:US20120101091A1
公开(公告)日:2012-04-26
The present application provides compounds of formula I wherein X, Y, R
2
, n, R
5
and R
6
are defined herein, useful as inhibitors of the hepatitis C virus NS5B polymerase The present application also provides pharmaceutical compositions containing said compounds, methods of using said compounds as pharmaceuticals alone or with other antiviral agent in the treatment of a hepatitis C viral infection in a mammal having or at risk of having the infection.